Global RNA Sequencing Analysis Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global RNA Sequencing Analysis Market Research Report 2024
RNA sequencing (RNA-Seq) uses the capabilities of high-throughput sequencing methods to provide insight into the transcriptome of a cell. Compared to previous Sanger sequencing- and microarray-based methods, RNA-Seq provides far higher coverage and greater resolution of the dynamic nature of the transcriptome. Beyond quantifying gene expression, the data generated by RNA-Seq facilitate the discovery of novel transcripts, identification of alternatively spliced genes, and detection of allele-specific expression. Recent advances in the RNA-Seq workflow, from sample preparation to library construction to data analysis, have enabled researchers to further elucidate the functional complexity of the transcription. In addition to polyadenylated messenger RNA (mRNA) transcripts, RNA-Seq can be applied to investigate different populations of RNA, including total RNA, pre-mRNA, and noncoding RNA, such as microRNA and long ncRNA.
According to Mr Accuracy reports’s new survey, global RNA Sequencing Analysis market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Sequencing Analysis market research.
Key companies engaged in the RNA Sequencing Analysis industry include Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Pacific Biosciences, Agilent Technologies and QIAGEN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of RNA Sequencing Analysis were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole RNA Sequencing Analysis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Sequencing Analysis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Pacific Biosciences
Agilent Technologies
QIAGEN
Segment by Type
Total RNA
Pre-mRNA
Noncoding RNA
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The RNA Sequencing Analysis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global RNA Sequencing Analysis market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Sequencing Analysis market research.
Key companies engaged in the RNA Sequencing Analysis industry include Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Pacific Biosciences, Agilent Technologies and QIAGEN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of RNA Sequencing Analysis were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole RNA Sequencing Analysis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Sequencing Analysis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Pacific Biosciences
Agilent Technologies
QIAGEN
Segment by Type
Total RNA
Pre-mRNA
Noncoding RNA
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The RNA Sequencing Analysis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source